📄 medicine

Associations of hs-CRP and Interleukin-6 with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Uzbekistan

This cross-sectional study from Uzbekistan demonstrates that elevated levels of high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) are independently associated with diabetic nephropathy in patients with type 2 diabetes, suggesting that chronic low-grade inflammation plays a significant role in the development of this kidney complication.

Original authors: Olimjan Nazirkulov, Nigora Abdullayeva, Shukhrat Ziyadullaev, Dildora Tulyaganova, Avaz Kodirov, Jonibek Kadirov, Kamila Eshbayeva, Hayrulla Ishonhajaev, Alisher Akhmedov, Mahzuna Nasretdinova, Umida

Published 2026-06-28

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Olimjan Nazirkulov, Nigora Abdullayeva, Shukhrat Ziyadullaev, Dildora Tulyaganova, Avaz Kodirov, Jonibek Kadirov, Kamila Eshbayeva, Hayrulla Ishonhajaev, Alisher Akhmedov, Mahzuna Nasretdinova, Umida Samibaeva, Nodirjon Ruzimurodov

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

The Big Picture: A "Fire" in the Body

Imagine your body is a house. Type 2 Diabetes is like a leaky pipe that keeps dripping water, slowly damaging the walls. One of the most serious rooms to get damaged is the kidney, which acts as the house's water filtration system. When this filter gets clogged or broken, it's called Diabetic Nephropathy.

Scientists have long suspected that this damage isn't just caused by the "leaky pipe" (high sugar) but also by a low-level fire burning inside the house. This fire is called inflammation.

This study, conducted in Uzbekistan, wanted to see if two specific "smoke detectors" could tell us if the kidney filter was getting damaged. These detectors are:

hs-CRP: A marker that lights up when there is general inflammation.
IL-6: A chemical messenger that signals the body to start a fire (inflammation).

The Experiment: Checking the Smoke Detectors

The researchers gathered 227 people with Type 2 Diabetes. They split them into two groups:

Group A (The Clean House): 95 people whose kidneys were working fine.
Group B (The Damaged House): 132 people who already had kidney damage (Diabetic Nephropathy).

They measured the levels of hs-CRP and IL-6 in everyone's blood, along with checking other things like age, blood pressure, and how long they had diabetes.

What They Found

The results were very clear, like seeing thick black smoke in one room and clear air in another:

Higher Smoke Levels: The people with kidney damage (Group B) had much higher levels of both hs-CRP and IL-6 compared to the healthy group.
- Analogy: If the healthy group had a faint wisp of smoke, the kidney-damage group had a roaring bonfire.
The "Independent" Fire: Even after the researchers accounted for other known troublemakers—like being older, having high blood pressure, or having diabetes for a long time—the "smoke" (inflammation) was still a strong predictor of kidney damage.
- Analogy: Imagine you are trying to guess which house is on fire. You know the house is old and the pipes are leaky. But even if you ignore those facts, the fact that you see smoke is still the best clue that the house is burning.

The "Scorecard" (Predicting the Damage)

The researchers built a "scorecard" to predict who has kidney damage.

Basic Scorecard: Using just age, blood pressure, and sugar levels, they could guess correctly about 81% of the time.
Adding the Smoke Detectors: When they added the inflammation markers (hs-CRP and IL-6) to the scorecard, the accuracy jumped up to 93%.
- Analogy: It's like trying to find a lost key in a dark room. With just a flashlight (basic info), you might find it. But if you add a thermal camera (inflammation markers), you can see the heat signature of the key and find it almost every time.

Interestingly, IL-6 was the "super detector." Adding IL-6 to the scorecard made a huge difference. Adding hs-CRP helped a little bit more, but IL-6 did the heavy lifting.

Other Clues Found

The study also confirmed what we already knew about the "leaky pipes":

Time: The longer you have diabetes, the more likely the damage is.
Pressure: High blood pressure makes the kidney filter work harder and break faster.
Sugar Spikes: Higher fasting blood sugar was linked to damage.
Surprise: Surprisingly, the long-term sugar average (HbA1c) didn't predict kidney damage as well as the current sugar levels (FPG) did in this specific group.

What the Study Doesn't Say

It is important to stick to what the paper actually claims:

No Causality: This study is a "snapshot" (cross-sectional). It shows that smoke and fire happen at the same time, but it doesn't prove that the smoke caused the fire. It just says they are strongly linked.
No New Treatments: The paper does not test new drugs or cures. It only looks at these markers to see if they are useful for identification.
Specific Location: These results are from Uzbekistan. While likely similar elsewhere, the study only speaks to this specific population.

The Bottom Line

In this group of patients in Uzbekistan, people with kidney damage had significantly higher levels of inflammation markers (hs-CRP and IL-6) than those without. These markers act like sensitive smoke detectors that can help identify patients at higher risk for kidney trouble, even when you already know their age and blood pressure. The study suggests that chronic, low-grade inflammation is a key part of the story behind diabetic kidney disease.

Technical Summary: Associations of hs-CRP and Interleukin-6 with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study from Uzbekistan

Problem Statement
Diabetic nephropathy is a leading microvascular complication of Type 2 Diabetes Mellitus (T2DM) and a primary driver of chronic kidney disease (CKD) globally. While chronic low-grade inflammation is hypothesized to contribute to the pathogenesis and progression of this condition, empirical data regarding specific inflammatory biomarkers in Central Asian populations, particularly in Uzbekistan, remain scarce. Existing literature suggests links between inflammation and diabetic complications, but the independent associations of high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) with diabetic nephropathy in this specific demographic have not been thoroughly investigated.

Methodology
This study employed a cross-sectional design involving 227 patients with T2DM recruited from the Samarkand Branch of the Republican Specialised Scientific and Practical Medical Centre of Endocrinology in Uzbekistan between January and March 2026. Participants were stratified into two groups: 95 patients with T2DM without microvascular complications and 132 patients with a documented clinical diagnosis of diabetic nephropathy.

Data Collection: Demographic, clinical, and laboratory data were extracted from medical records. Key variables included age, sex, hypertension status, smoking, Body Mass Index (BMI), duration of diabetes, Fasting Plasma Glucose (FPG), HbA1c, estimated glomerular filtration rate (eGFR), and urinary albumin-to-creatinine ratio (UACR).
Biomarker Measurement: Serum levels of hs-CRP and IL-6 were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits (Vector-Best, Russia).
Statistical Analysis: Group comparisons utilized the Mann–Whitney U test for continuous variables and the Chi-square test for categorical variables. Multivariable logistic regression was performed to assess independent associations, utilizing four sequential models:
- Model 1: Adjusted for age, sex, smoking, hypertension, diabetes duration, BMI, FPG, and HbA1c.
- Model 2: Model 1 + hs-CRP.
- Model 3: Model 1 + IL-6.
- Model 4: Model 1 + both hs-CRP and IL-6.
- Additional analyses included Spearman correlation and Receiver Operating Characteristic (ROC) curve analysis to evaluate predictive discrimination.

Key Results

Demographic and Clinical Differences: Patients with diabetic nephropathy were significantly older (median 61 vs. 52 years), had a longer duration of diabetes (median 14 vs. 10 years), and exhibited a higher prevalence of hypertension (78.8% vs. 54.2%) compared to the uncomplicated group.
Biomarker Levels: Both inflammatory markers were significantly elevated in the nephropathy group. Hs-CRP levels were 7.50 mg/L (IQR: 5.40–8.60) versus 4.54 mg/L (IQR: 3.40–6.38) in the control group ( $p < 0.001$ ). IL-6 levels were 13.30 pg/mL (IQR: 11.28–16.20) versus 8.40 pg/mL (IQR: 5.55–10.60) ( $p < 0.001$ ).
Multivariable Associations: In the fully adjusted Model 4, both hs-CRP (Adjusted Odds Ratio [AOR] 1.28, 95% CI 1.07–1.54) and IL-6 (AOR 1.50, 95% CI 1.31–1.72) remained independently associated with diabetic nephropathy. Other independent risk factors identified included longer diabetes duration, hypertension, and higher FPG levels. Age, sex, smoking, BMI, and HbA1c were not independently associated in the final model.
Correlations: Spearman correlation analysis revealed that both biomarkers were positively correlated with UACR and negatively correlated with eGFR. IL-6 demonstrated stronger correlations with renal parameters ( $\rho = 0.574$ for UACR; $\rho = -0.516$ for eGFR) compared to hs-CRP.
Predictive Performance: ROC analysis indicated that adding inflammatory biomarkers improved the model's discriminatory ability. The clinical-only model (Model 1) had an Area Under the Curve (AUC) of 0.814. The addition of IL-6 (Model 3) significantly increased the AUC to 0.926, and the combined model (Model 4) achieved the highest AUC of 0.933. DeLong's test showed that Model 3 significantly outperformed Model 2, suggesting IL-6 contributed the majority of the incremental predictive value.

Significance and Claims
The authors claim that this study provides novel evidence from a Central Asian population, specifically Uzbekistan, regarding the role of chronic low-grade inflammation in diabetic nephropathy. The paper asserts that:

Independent Association: Elevated levels of hs-CRP and IL-6 are independently associated with diabetic nephropathy in T2DM patients, even after controlling for established clinical and glycaemic risk factors.
Biomarker Utility: These inflammatory markers, particularly IL-6, may serve as useful biomarkers for identifying patients at increased risk of diabetic kidney complications.
Predictive Enhancement: The inclusion of IL-6 and hs-CRP substantially enhances the predictive accuracy of models used to discriminate between patients with and without diabetic nephropathy.

The study concludes that these findings support the hypothesis that chronic inflammation contributes to the development and progression of diabetic nephropathy. However, the authors maintain a modest tone regarding causality, explicitly noting that the cross-sectional design precludes the establishment of causal relationships. They emphasize the need for future prospective studies to validate these findings and assess their clinical utility in risk stratification.